相关实验视频
Updated: Jan 9, 2026

03:36
Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
739
食道癌新辅助疗法的研究趋势:一个书法计量和元分析
Huaiyong Wang1, Jian Zhang1, Jiankun Yang1
1Department of Thoracic Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Frontiers in immunology
|December 5, 2025
概括
新辅助免疫疗法 (NIT) 是对食道癌的日益增长的研究领域. 虽然化疗和化疗放射治疗是标准的,但NIT显示出有希望的结果,但需要在大型试验中进一步验证.
科学领域:
- 在瘤学瘤学.
- 医学研究 医学研究
背景情况:
- 经过彻底手术后的新辅助治疗是局部晚期食道癌的标准.
- 该领域正在经历研究量和不断发展的治疗策略的显著增长.
研究的目的:
- 对食道癌的新辅助疗法分析趋势和研究热点.
- 通过元分析来比较不同新辅助治疗方案的疗效和安全性.
主要方法:
- 自2000年以来,从Web of Science核心收藏中对1,324篇出版物的图书统计分析.
- 对27项III期随机对照试验的元分析,比较新辅助疗法.
- 使用CiteSpace,VOSviewer和RStudio进行文献计量;使用Stata/MP进行元分析.
主要成果:
- 出版量正在增加,美国在研究成果方面处于领先地位.
- 新辅助化疗 (NCT) 和化学辐射疗法 (NCRT) 已经建立,最近的重点是新辅助免疫疗法 (NIT).
- 综合完整的病理反应率有所不同:NCT (0.08),NCRT (0.29),新辅助化疗免疫疗法 (NCIT) (0.22),以及NCRT+NTT (0.27).
结论:
- 对于食道癌的新辅助疗法已经发展,NIT成为一个关键的研究重点.
- 临床疗效和NIT的安全性需要通过长期III期RCT数据进一步验证.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Barrett Esophagus-I: Introduction
572
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
572
Barrett Esophagus-II: Clinical Manifestations and Management
743
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
743
Cancer Survival Analysis
630
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
630
Esophageal Varices-II: Clinical Features and Management
343
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
343

